Isolation and properties of a new kallikrein inhibitor from Tityus serrulatus venom

Journal of Protein Chemistry

Volumn 17, Issue 8, 1998, Pages 799-805

  Ferreira, L A F ^a   Zingalli, R ^b   Habermehl, G ^c   Lebrun, I ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Inhibitor; Kallikrein; Tityus serrulatus; Venom

Indexed keywords

KALLIKREIN; KALLIKREIN INHIBITOR; KININOGEN; PANCREAS ENZYME; SCORPION VENOM;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; ENZYME INHIBITION; GEL FILTRATION CHROMATOGRAPHY; GUINEA PIG; ILEUM; NONHUMAN; PLASMA; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN STABILITY; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SWINE; URINE;

AMINO ACID SEQUENCE; ANIMALS; APROTININ; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GUINEA PIGS; HEAT; HYDROGEN-ION CONCENTRATION; INHIBITORY CONCENTRATION 50; KALLIKREINS; KININS; MALE; MOLECULAR SEQUENCE DATA; PANCREAS; RATS; RATS, WISTAR; SCORPION VENOMS; SERINE PROTEINASE INHIBITORS;

ANIMALIA; CAVIA PORCELLUS; INVERTEBRATA; SCORPIONES; SUIDAE; SUS SCROFA; TITYUS SERRULATUS;

EID: 54749123578     PISSN: 02778033     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020778302161     Document Type: Article

References (23)

1. Amaral, C. F. S., and Rezende, N. A. (1997). Both cardiogenic and non-cardiogenic factors are involved in the pathogenesis of pulmonary oedema after scorpion envenoming, Toxicon 35, 997-998.
2. Castania, A., and Rothschild, A. M. (1974). Lowering of kininogen in the rat blood by adrenaline and its inhibition by symphatolytic agents, heparin and aspirin, Br. J. Pharmacol. 50, 375-381.
3. Colman, R. W., and Wong, P. Y. (1979). Kallikrein-kinin system in pathologic conditions, In: Handbook of Experimental Pharmacology, Vol. XXV (Supplement): Bradykinin, Kallidin, and Kallikrein (Erdos, E. G., ed.), Springer, Berlin.
4. De Matos, M. I., Rocha, A. O., Leite, R., and Freire-Maia, L. (1997). Lung oedema induced by Tityus serrulatus scorpion venom in rat, Comp. Biochem. Physiol. 118C, 143-148.
5. Edman, P. (1950). Method for determination of amino acid sequence in peptides, Acta Chem. Scand. 10, 710-768.
6. Ferreira, L. A. F., Alves, E. W., and Henriques, O. B. (1993a). Peptide T, a novel bradykinin potentiator isolated from Tityus serrulatus scorpion venom, Toxicon 31, 941-947.
7. Ferreira, L. A. F., Bergamasco, M., and Henriques, O. B. (1993b). Crude venom from the scorpion Tityus serrulatus inhibits angiotensin-converting enzyme activity in the rat, J. Nat. Toxins 3, 145-153.
8. Ferreira, L. A. F., Bergamasco, M., and Henriques, O. B. (1994). Isolation and properties of a T-kininogenase from bovine erythrocyte membranes, J. Protein Chem. 13, 547-552.
9. ++ concentrations in rat urine after intraperitoneal injection of Tityus serrulatus venom, J. Venom Anim. Toxins 2, 156-161.
10. Freire-Maia, L., and Campos, J. A. (1987). Response to the Letter to the Editor by Gueron and Ovysyshcher on the treatment of the cardiovascular manifestations of the scorpion envenomation, Toxicon 25, 125-130.
11. Freire-Maia, L., and Campos, J. A. (1989). Pathophysiology and treatment of scorpion poisoning, In: Natural Toxins. Characterization, Pharmacology and Therapeutics (Ownby, C. L., and Odell, G. V., eds.), Pergamon Press, Oxford.
12. Freire-Maia, L., Pinto, G. I., and Franco, I. (1974). Mechanism of the cardiovascular effects produced by purified scorpion toxin in the rat, J. Pharm. Exp. Ther. 188, 207-213.
13. Freire-Maia, L., Almeida, H. O., Cunha-Mello, J. R., Azevedo, A. D., and Barroso, J. (1978). Mechanism of the pulmonary oedema induced by intravenous injection of scorpion toxin in the rat, Agents Actions 8, 113-118.
14. Friberger, P., Aurell, L., and Claeson, G. (1982). Chromogenic substrate of kallikrein and related enzymes, Agents Actions 9, 83-90.
15. Geiger, R., Stuckstedte, U., and Fritz, H. (1980). Isolation and characterization of human urinary kallikrein. Hoppe-Zeyler's Z. Physiol. Chem. 361, 1003-1016.
16. Hojima, Y., Isobe, M., and Moryia, H. (1977). Kallikrein inhibitor in rat plasma, J. Biochem. 81, 37-46.
17. Ismail, M., Fatani, J. Y., and Babees, T. T. (1992). Experimental treatment protocols for scorpion envenomation: A review of common therapies and an effect of kallikrein-kinin inhibitors, Toxicon 30, 1257-1279.
18. 4, Nature 217, 680-685.
19. Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. (1951). Protein measurement with folin reagent, Biol. Chem. 192, 265-275.
20. Oliva, M. L., Grisolia, D., Sampaio, M. V., and Sampaio, C. A. M. (1982). Properties of hightly purified human plasma kallikrein, Agents Actions Suppl. 9, 52-57.
21. Rothschild, A. M., and Castania, A. (1976). Contribution of vasopressor and kininogen changes towards acute adrenaline pulmonary edema in rat. Naunyn-Schmiedebergs Arch. Pharmacol. 295, 117-181.
22. Shimamoto, K., and Limura, O. (1992). The renal kallikrein-kinin system at the prehypertensive stage of hypertension, Agents Actions Suppl. 38, 287-293.
23. Vogel, R. (1979), Kallikrein inhibitors, In: Handbook of Experimental Pharmacology, Vol. XXV (Supplement): Bradykinin, Kallidin, and Kallikrein (Erdos, E. G., ed.), Springer, Berlin, pp. 163-225.